Pfizer (PFE)Rep. Laurel Lee (FL15) disclosed a purchase $15K–$50K
Rep. Laurel Lee (FL15) disclosed a purchase of Pfizer in the $15K–$50K range.
- $15,001–$50,000
- Reported range · official band, not an exact amount
- 31 days
- Disclosure lag
- Traded
- Oct 21, 2024
- Disclosed
- Nov 21, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 9, 2024CongressDisclosed sale of PFE — reported range $1,001 - $15,000
- Sep 12, 2024FDAFDA drug approval: Mektovi
- Sep 12, 2024FDAFDA drug approval: Braftovi
- Oct 11, 2024FDAFDA drug approval: Hympavzi
- Oct 15, 2024FDAFDA drug approval: Fragmin
- Oct 15, 2024CongressDisclosed sale of PFE — reported range $1,001 - $15,000
- Oct 21, 2024 · this disclosureCongressDisclosed purchase of PFE — reported range $15,001 - $50,000
What came next
- Oct 30, 2024InsiderDirector purchased ~$28K of PFE shares in the open market
- Dec 20, 2024FDAFDA drug approval: Braftovi
- Dec 20, 2024Layoff notice · Heights Union East, 2002 N. 6th Floor, TAMPA, FL, 33602Layoff notice filed in FL: 62 employees
- Jan 15, 2025CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
- Jan 24, 2025CongressDisclosed partial sale of PFE — reported range $1,001 - $15,000
- Jan 31, 2025FDAFDA drug approval: Paxlovid (Copackaged)
- Feb 13, 2025InsiderDirector purchased ~$499K of PFE shares in the open market
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Pfizer
For Pfizer, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 54 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PFE page.
Other recent filings by Rep. Laurel Lee (FL15)
- House Clerk periodic transaction report at Bank of America (BAC)Jul 19, 2026
- House Clerk periodic transaction report at GE Aerospace (GE)Jul 19, 2026
- House Clerk periodic transaction report at Warner Bros. Discovery (WBD)Aug 11, 2025
- House Clerk periodic transaction report at Tuhura Biosciences, Inc./Nv (HURA)Aug 9, 2025
- House Clerk periodic transaction report at Tuhura Biosciences, Inc./Nv (HURA)Jan 7, 2025
The full history of Rep. Laurel Lee (FL15) is on the profile page.
How this filing works
Other disclosures at Pfizer
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its PFE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data